- Home
- ROIV vs AN Comparison
ROIV vs AN Comparison
Compare ROIV & AN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- AN
- Stock Information
- Founded
- ROIV 2014
- AN 1991
- Country
- ROIV United Kingdom
- AN United States
- Employees
- ROIV N/A
- AN N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- AN Other Specialty Stores
- Sector
- ROIV Health Care
- AN Consumer Discretionary
- Exchange
- ROIV Nasdaq
- AN Nasdaq
- Market Cap
- ROIV 8.4B
- AN 7.2B
- IPO Year
- ROIV N/A
- AN N/A
- Fundamental
- Price
- ROIV $10.68
- AN $181.31
- Analyst Decision
- ROIV Strong Buy
- AN Buy
- Analyst Count
- ROIV 8
- AN 9
- Target Price
- ROIV $17.93
- AN $204.13
- AVG Volume (30 Days)
- ROIV 4.0M
- AN 511.0K
- Earning Date
- ROIV 02-10-2025
- AN 02-11-2025
- Dividend Yield
- ROIV N/A
- AN N/A
- EPS Growth
- ROIV N/A
- AN N/A
- EPS
- ROIV N/A
- AN 16.92
- Revenue
- ROIV $122,585,000.00
- AN $26,765,400,000.00
- Revenue This Year
- ROIV $15.98
- AN $3.71
- Revenue Next Year
- ROIV N/A
- AN $3.72
- P/E Ratio
- ROIV N/A
- AN $10.72
- Revenue Growth
- ROIV 140.04
- AN N/A
- 52 Week Low
- ROIV $9.76
- AN $137.26
- 52 Week High
- ROIV $13.06
- AN $198.50
- Technical
- Relative Strength Index (RSI)
- ROIV 42.58
- AN 41.07
- Support Level
- ROIV $10.33
- AN $185.36
- Resistance Level
- ROIV $10.86
- AN $195.03
- Average True Range (ATR)
- ROIV 0.27
- AN 4.74
- MACD
- ROIV 0.02
- AN -1.41
- Stochastic Oscillator
- ROIV 29.96
- AN 3.48
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About AN AutoNation Inc.
AutoNation is the second largest automotive dealer in the United States, with 2023 revenue of about $27 billion and over 250 dealerships, plus 53 collision centers. The firm also has 23 AutoNation USA used-vehicle stores, a captive lender, four auction sites, and three parts distributors all across 21 states primarily in Sunbelt metropolitan areas. New-vehicle sales account for nearly half of revenue; the company also sells used vehicles, parts, and repair services as well as auto financing. The company (formerly Republic Industries) spun off its waste management unit (Republic Services) in 1999 and its car rental businesses (ANC Rental) in 2000. Wayne Huizenga founded the company in the 1990s to bring the rollup acquisition strategy to auto retailing, which has proved to be a smart move.